Enriqueta Vallejo-Yagüe

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 14

Top Topics

Rheumatoid Arthritis

Top Venues

Journal of clinical medicine

Rheumatology advances in practice

This page only lists publications with an associated author ORCID identifier.

Publications

Enriqueta Vallejo-Yagüe, Theresa Burkard, Axel Finckh, Andrea Michelle Burden, null null
Comparative effectiveness of biologics in patients with rheumatoid arthritis stratified by body mass index: a cohort study in a Swiss registry. BMJ open 14 (2) (2024)
Enriqueta Vallejo-Yagüe, Theresa Burkard, Axel Finckh, Andrea Michelle Burden, null null
Comparative effectiveness of biologics in patients with rheumatoid arthritis stratified by body mass index: a cohort study in a Swiss registry. BMJ open 14 (2) (2024)
Enriqueta Vallejo-Yagüe, Theresa Burkard, Axel Finckh, Andrea Michelle Burden, null null
Comparative effectiveness of biologics in patients with rheumatoid arthritis stratified by body mass index: a cohort study in a Swiss registry. BMJ open 14 (2) (2024)
Enriqueta Vallejo-Yagüe, Theresa Burkard, Axel Finckh, Andrea Michelle Burden, null null
Comparative effectiveness of biologics in patients with rheumatoid arthritis stratified by body mass index: a cohort study in a Swiss registry. BMJ open 14 (2) (2024)
Chloé Pasin, Camila Rosat Consiglio, Jana Sanne Huisman, Ann-Marie Glasø de Lange, Hannah Peckham, Enriqueta Vallejo-Yagüe, Irene A Abela, Ulrika Islander, Nadia Neuner-Jehle, Maria Pujantell, Olivia Roth, Melanie Schirmer, Burcu Tepekule, Marius Zeeb, Anna Hachfeld, Karoline Aebi-Popp, Roger D Kouyos, Sebastian Bonhoeffer
Sex and gender in infection and immunity: addressing the bottlenecks from basic science to public health and clinical applications. Royal Society open science 10 (7) (2023)
Maria Luisa Faquetti, Enriqueta Vallejo-Yagüe, René Cordtz, Lene Dreyer, Andrea Michelle Burden
JAK-inhibitors and risk on serious viral infection, venous thromboembolism and cardiac events in patients with rheumatoid arthritis: A protocol for a prevalent new-user cohort study using the Danish nationwide DANBIO register. PloS one 18 (7) (2023)
Enriqueta Vallejo-Yagüe, Theresa Burkard, Raphael Micheroli, Andrea Michelle Burden
Minimal disease activity and remission in patients with psoriatic arthritis with elevated body mass index: an observational cohort study in the Swiss Clinical Quality Management cohort. BMJ open 12 (9) (2022)
Enriqueta Vallejo-Yagüe, Julia N Pfund, Theresa Burkard, Carole Clair, Raphael Micheroli, Burkhard Möller, Axel Finckh, Andrea Michelle Burden
Lower odds of remission among women with rheumatoid arthritis: A cohort study in the Swiss Clinical Quality Management cohort. PloS one 17 (10) (2022)
Theresa Burkard, Enriqueta Vallejo-Yagüe, Thomas Hügle, Axel Finckh, Andrea Michelle Burden
Interruptions of biological and targeted synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: a descriptive cohort study assessing trends in patient characteristics in Switzerland. BMJ open 12 (3) (2022)
Enriqueta Vallejo-Yagüe, Adrian Martinez-De la Torre, Omar S Mohamad, Shweta Sabu, Andrea Michelle Burden
Drug Triggers and Clinic of Acute Generalized Exanthematous Pustulosis (AGEP): A Literature Case Series of 297 Patients. Journal of clinical medicine 11 (2) (2022)
Enriqueta Vallejo-Yagüe, Edward C Keystone, Sreemanjari Kandhasamy, Raphael Micheroli, Axel Finckh, Andrea Michelle Burden
Primary and secondary non-response: in need of operational definitions in observational studies. Annals of the rheumatic diseases (2021)
Enriqueta Vallejo-Yagüe, Theresa Burkard, Burkhard Möller, Axel Finckh, Andrea Michelle Burden
Comparison of Psoriatic Arthritis and Rheumatoid Arthritis Patients across Body Mass Index Categories in Switzerland. Journal of clinical medicine 10 (14) (2021)
Annika Vestergaard Kvist, Junaid Faruque, Enriqueta Vallejo-Yagüe, Stefan Weiler, Elizabeth M Winter, Andrea Michelle Burden
Cardiovascular Safety Profile of Romosozumab: A Pharmacovigilance Analysis of the US Food and Drug Administration Adverse Event Reporting System (FAERS). Journal of clinical medicine 10 (8) (2021)
Theresa Burkard, Ross D Williams, Enriqueta Vallejo-Yagüe, Thomas Hügle, Axel Finckh, Diego Kyburz, Andrea Michelle Burden
Prediction of sustained biologic and targeted synthetic DMARD-free remission in rheumatoid arthritis patients. Rheumatology advances in practice 5 (3) (2021)